Amneal to Participate in Upcoming Investor Conference

Company Overview - Amneal Pharmaceuticals, Inc. is a diversified global biopharmaceutical leader focused on expanding access to affordable and innovative medicines [2] - Founded in 2002 by brothers Chirag and Chintu Patel, the company operates with the belief that innovation matters only if it is accessible [2] - Amneal has a portfolio of approximately 300 complex, specialty, and biosimilar medicines, delivering over 160 million prescriptions annually, primarily in the United States [2] Business Segments - The Affordable Medicines segment includes retail, injectable, and biosimilar products [2] - The Specialty segment provides branded treatments in neurology, including conditions such as Parkinson's disease and migraine, as well as in endocrinology [2] - The AvKARE segment distributes pharmaceuticals and medical products to U.S. federal, retail, and institutional customers [2] Upcoming Events - Chirag Patel, Co-Chief Executive and President, will participate in a fireside chat at the Barclays 28th Annual Global Healthcare Conference on March 10, 2026, at 11:00 AM EST in Miami, FL [1] - A webcast of the presentation will be available on Amneal's Investor Relations website, with a replay accessible after the event [1]